On Wednesday, August 3, you are invited to join Health Affairs Editor-in-Chief Alan Weil for the next installment of our Policy Spotlight series, featuring Robert M. Califf, M.D., the Biden appointed Commissioner of the Food and Drug Administration (FDA). This will be a free event that is open to all.
As the top official of the FDA, Dr. Califf is oversees programs and policies that to protect and promote the public health. Previously, Dr. Califf served as Commissioner of Food and Drugs from February 2016 to January 2017, and as the FDA’s Deputy Commissioner for Medical Products and Tobacco.
Prior to rejoining the FDA, Dr. Califf was head of medical strategy and Senior Advisor at Alphabet Inc., contributing to strategy and policy for its health subsidiaries Verily Life Sciences and Google Health.
Earlier, Dr. Califf was a professor of medicine and vice chancellor for clinical and translational research at Duke University, director of the Duke Translational Medicine Institute and the Duke Clinical Research Institute.
Health Affairs is the leading peer-reviewedjournalat the intersection of health, health care, and policy. Published monthly by Project HOPE, the journal is available in print and online. Late-breaking
content is also found through healthaffairs.org, Health Affairs Today, and Health Affairs Sunday Update.
Project HOPE is a global health and humanitarian relief organization that places power in the hands of local health care workers to save lives across the globe. Project HOPE has published Health Affairs since 1981.
